Skip to main content
;

HESA Committee Report

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

PDF

APPENDIX A: LIST OF WITNESSES 41-1

41st Parliament – First Session

Organizations and Individuals

Date

Meeting

Brain Canada Foundation

Inez Jabalpurwala, President and CEO

2012/03/01

31

David Kaplan, Vice-Chair, Science

   

Canadian Institutes of Health Research

Alain Beaudet, President

   

Neurological Health Charities Canada

Vanessa Foran, Director,
Policy, Partnerships and Government Relations

   

Celina Rayonne-Chavannes, Director,
Research Initiatives

   

Public Health Agency of Canada

Kim Elmslie, Director General,
Centre for Chronic Disease Prevention and Control, Health Promotion and Chronic Disease Prevention Branch

   

As an individual

Bin Hu, Professor,
Department of Clinical Neurosciences, University of Calgary

2012/04/26

40

David Simmonds

   

Parkinson Society Canada

Edward Fon, Director,
McGill Parkinson Program and National Parkinson Foundation Center of Excellence, Montreal Neurological Institute, McGill University

   

Joyce Gordon, President and Chief Executive Officer

   

University of Ottawa

Daniel Krewski, Professor and Director,
R. Samuel McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health

   

Amyotrophic Lateral Sclerosis (ALS) Society of Canada

Derek Walton, Member of Advocacy Committee

2012/05/01

41

Baycrest Hospital

Galit Kleiner-Fisman, Neurologist and Movement Disorders Specialist

   

Multiple Sclerosis Society of Canada

Deanna Groetzinger, Vice-Chair,
Government Relations and Policy

2012/05/01

41

Marie Vaillant, Vice-Chair,
Ontario Division Board of Directors

   

Neurological Health Charities Canada

Garth M. Bray, Chair,
Scientific Advisory Committee

   

Ian McDowell, Vice-Chair,
Scientific Advisory Committee